Unlock regulatory insights with Watson. Learn More
Return to Docket

Patent Term Extension Application for JEVTANA® (cabazitaxel), U.S. Patent No. 5,847,170

Type: Non-Rule Making
KeyWord(s) CDER, cabazitaxel, JEVTANA®, Patent Term Extension Application , U.S. Patent No. 5,847,170
Docket Item Code E
Center CDER

0 Comments

Click here to view all comments of this document.